GE HealthCare Files 8-K

TL;DR

GE HealthCare filed a routine 8-K on Dec 1st, no major news yet.

AI Summary

GE HealthCare Technologies Inc. filed an 8-K on December 2, 2025, reporting events as of December 1, 2025. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided text. The company is incorporated in Delaware and headquartered in Chicago, IL.

Why It Matters

This 8-K filing indicates routine corporate reporting by GE HealthCare Technologies Inc. as of December 1, 2025, without immediate disclosure of significant new events.

Risk Assessment

Risk Level: low — The filing appears to be routine and does not disclose any immediate material risks or changes.

Key Numbers

• 001-41528 — SEC File Number (Identifies the company's filing with the SEC)
• 88-2515116 — IRS Employer Identification No. (Company's tax identification number)

Key Players & Entities

• GE HealthCare Technologies Inc. (company) — Registrant
• Delaware (jurisdiction) — State of incorporation
• Chicago, IL (location) — Principal executive offices

FAQ

From the Filing

0001193125-25-305400.txt : 20251202 0001193125-25-305400.hdr.sgml : 20251202 20251202165521 ACCESSION NUMBER: 0001193125-25-305400 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20251201 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251202 DATE AS OF CHANGE: 20251202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 251543888 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 8-K 1 d84660d8k.htm 8-K 8-K false 0001932393 0001932393 2025-12-01 2025-12-01     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 1, 2025     GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter)       Delaware   001-41528   88-2515116 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 500 W. Monroe Street , Chicago , IL     60661 (Address of principal executive offices)     (Zip Code) (Registrant’s telephone number, including area code) (833) 735-1139   (Former name or former address, if changed since last report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common stock, par value $0.01 per share   GEHC   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐       Item 8.01 Other Events. On December 1, 2025, GE HealthCare Technologies Inc. (the “Company”) commenced and priced an underwritten offering (the “Offering”) of $600,000,000 aggregate principal amount of 4.150% Notes due December 15, 2028 (the “2028 Notes”) and $650,000,000 aggregate principal amount of 4.950% Notes due December 15, 2035 (the “2035 Notes” and, together with the 2028 Notes, the “Notes”) pursuant to the registration st